GovChime
Notice ID: 4382def9c19c4bc33c12c07b84305ff5Combined Synopsis/Solicitation

66--Sole Source Antibodies

Archived on December 3, 2013. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
7:00 AM UTC+02:00
Posted
October 4, 2013
Notice type
Combined Synopsis/Solicitation
NAICS
334516: Analytical Laboratory Instrument Manufacturing

Notice details

Place of performance
US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD 21702-5014 US
PSC
66: INSTRUMENTS AND LABORATORY EQPT
Last updated
Dec 3, 2025

Identifiers

Solicitation number
W81XWH13T0411
Notice ID
4382def9c19c4bc33c12c07b84305ff5

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Institute of Surgical Research (USAISR) is soliciting a sole source acquisition for antibodies manufactured by Georg-August-Universitat Stiftung Offentlichen Rechts; Universitatsmedizin, Robert-Koch-Str. 42, 37099 Gottingen, Germany. Specifically, the Government will purchase the following antibodies: 4400 ug Z22/8 (anti-C3; 14,6 mg/ml) 1000 ug biotinylate K5/4 (anti-C3a; 0,58 mg/ml) 2200 ng hog C3a Standard (5 ug/ml) 2mg Z22/8 (anti-C3a) 2mg T13/9 (anti-C5a) The purchase of these specific antibodies is to study the role of the complement system in a trauma and the use of complement inhibitors to treat traumatic hemorrhage. These antibodies are the only available antibodies on the market that specially targets porcine complement components, C5a and C3a. Currently, no other vendor sells or distributes porcine specific antibodies for the complement components C5a and C3a. If you have any questions, please contact James Cheng at 301-619-1012 or electronically at james.cheng1.civ@mail.mil Please provide the following items when responding to this solicitation: -DUNS# -CAGE Code -TAX ID# (TIN) -Discount Terms (i.e. Net 30) -Delivery Time -Contact Information (Name, Telephone Number, Fax Number, and Email) -Any Shipping Cost

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

James Cheng, 301-619-1012 US Army Medical Research Acquisition Activity

Documents

No documents available.

Lifecycle

Solicitation:W81XWH13T0411
  1. Combined Synopsis
  1. Special NoticeSep 18, 2013

    66--Notice of Intent to Sole Source for Antibodies

    Notice 6e8874566d85b4cb0bd7538fda57f626 on SAM.gov

  2. Combined SynopsisCurrentOct 4, 2013

    66--Sole Source Antibodies

    Notice 4382def9c19c4bc33c12c07b84305ff5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81XWH13T0411

Archive Date

Dec 3, 2013